Praxis Precision Medicines, Inc. SEC filings PRAX

Praxis Precision Medicines, Inc. has 510 filings in SEC EDGAR's recent list, going back to Nov 10, 2016. Its latest annual report, Form 10-K, was filed on Feb 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.

Praxis Precision Medicines, Inc. SEC filings
Form Description Filed Period
EFFECT Filing Mar 12, 2024 —
CORRESP Letter to the SEC Mar 8, 2024 —
UPLOAD Letter from the SEC Mar 8, 2024 —
EFFECT Filing Feb 9, 2023 —
POSASR Filing Feb 7, 2023 —
EFFECT Filing May 18, 2021 —
EFFECT Filing May 13, 2021 —
CORRESP Letter to the SEC May 11, 2021 —
CORRESP Letter to the SEC May 11, 2021 —
UPLOAD Letter from the SEC Mar 19, 2021 —
DRS Filing Mar 18, 2021 —
SEC STAFF LETTER Filing Oct 21, 2020 —
EFFECT Filing Oct 15, 2020 —
CERT Filing Oct 15, 2020 —
CORRESP Letter to the SEC Oct 15, 2020 —
8-A12B Filing Oct 14, 2020 —
UPLOAD Letter from the SEC Oct 14, 2020 —
CORRESP Letter to the SEC Oct 13, 2020 —
CORRESP Letter to the SEC Oct 13, 2020 —
CORRESP Letter to the SEC Oct 9, 2020 —
UPLOAD Letter from the SEC Oct 7, 2020 —
SEC STAFF LETTER Filing Sep 22, 2020 —
UPLOAD Letter from the SEC Sep 10, 2020 —
DRSLTR Filing Aug 28, 2020 —
DRS/A Filing Aug 28, 2020 —
UPLOAD Letter from the SEC Aug 19, 2020 —
DRS Filing Jul 22, 2020 —
D Filing Jun 27, 2019 —
D Filing Mar 26, 2018 —
D Filing Nov 10, 2016 —

Showing 30 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PRAX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Boston, MA
SEC filer status
Large accelerated filer
SEC CIK
1689548

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.